EUVIMEDEUVIMED entdecken
Crossref

Perceptions and Use of Germline Genetic Testing Among Patients With Prostate Cancer

Laura B Beidler iD, Kimberly Zayhowski iD, Mary Nahorniak iD, Stephanie Loo iD, Gretchen A Gignac iD, Catharine Wang iD, Christine M Gunn iD

JCO Oncology Practice · 2025

DOI: 10.1200/op-24-00624 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Practice, 2025. Verfasst von Laura B Beidler und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Lebanon, NH. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Genetic Testing, Germ-Line Mutation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Many patients with prostate cancer are eligible for germline genetic testing, but it is underutilized in clinical practice. We aimed to explore perceptions of and decision making about undergoing genetic testing among patients with prostate cancer. METHODS This qualitative interview study enrolled patients diagnosed with prostate cancer who had been treated at a safety-net hospital and had received a referral for genetic testing in the previous 12 months. Participants completed an interview in their native language via telephone. Data on genetic testing use were captured in interviews and via the medical record. A thematic analysis explored factors related to decision making in concert with genetic testing use. RESULTS Thirty-three English-speaking (n = 25), Spanish-speaking (n = 6), and Haitian Creole–speaking (n = 2) patients completed interviews. In interviews, 19 reported completing genetic testing, 10 reported no testing, and four were unsure. Medical records indicated 24 had undergone genetic testing—including six participants whose self-reported testing status was no or unsure. Four main themes identified factors that influenced participant-reported genetic testing decisions: gendered perceptions of value to family, personal utility of genetic results, preferences for information, and relative priority of testing. Many participants did not view testing as a priority and delayed or declined testing because of cancer treatment burden. CONCLUSION These results suggest opportunities to improve communication about testing purpose, value, and utility in those affected by cancer. Conversations about the utility of both the individual benefit of obtaining genetic testing for those affected by prostate cancer and implications for familial cascade testing are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsGenetic TestingGerm-Line MutationHumansMaleMiddle AgedAgedDecision MakingPerceptionQualitative Research

Autor:innen und Institutionen

  • Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Lebanon, NH.
  • Department of Obstetrics and Gynecology, Boston University Chobanian and Avedisian School of Medicine, Boston, MA.
  • Graduate Medical Sciences, Boston University Chobanian and Avedisian School of Medicine, Boston, MA.
  • Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, MA.
  • Section of Hematology and Oncology, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, MA.
  • Boston Medicine Center, Boston, MA.

ORCID-Profile: Laura B Beidler, Kimberly Zayhowski, Mary Nahorniak, Stephanie Loo, Gretchen A Gignac, Catharine Wang, Christine M Gunn

Zitieren

APA

Beidler, L. B., Zayhowski, K., Nahorniak, M., Loo, S., Gignac, G. A., Wang, C., & Gunn, C. M. (2025). Perceptions and Use of Germline Genetic Testing Among Patients With Prostate Cancer. JCO Oncology Practice. https://doi.org/10.1200/op-24-00624

Vancouver

Beidler LB, Zayhowski K, Nahorniak M, Loo S, Gignac GA, Wang C, et al. Perceptions and Use of Germline Genetic Testing Among Patients With Prostate Cancer. JCO Oncology Practice. 2025. doi:10.1200/op-24-00624

BibTeX
@article{Beidler2025,
  author = {Beidler, Laura B and Zayhowski, Kimberly and Nahorniak, Mary and Loo, Stephanie and Gignac, Gretchen A and Wang, Catharine and Gunn, Christine M},
  title = {Perceptions and Use of Germline Genetic Testing Among Patients With Prostate Cancer},
  journal = {JCO Oncology Practice},
  year = {2025},
  doi = {10.1200/op-24-00624}
}
Kostenlos starten →